Innovations in Pharmaceutical Technology (IPT)

Concept Life Sciences Partners with OpenBench to Deliver Success-Based Drug Discovery Services for Early-Stage Biotech 21 May 2026 -- Chapel-en-le-Frith, UK and California, US -- Concept Life Sciences, a leading global contract research organization (CRO) with expertise in integrated drug discovery and development, and OpenBench, a pioneer of success-based AI hit discovery, today announced a strategic partnership to accelerate hit identification for biotech companies through a fee-for-success...

Nuclera launches antibody triage service to advance AI-driven antibody discovery Rapid binder triage, of AI-driven candidate sets, enables early elimination of non-binders ahead of costly downstream workflows Powered by cell-free technology to convert AI-generated candidates into experimental binding data.

Bio-Rad Expands Range of TrailBlazer Kits for Antibody Conjugation to StarBright Dyes Expanded Range Increases Access to Bio-Rad’s StarBright Dyes for Flow Cytometry and Western Blot Applications in Immunology Research 5 May 2025 -- California, US -- Bio-Rad Laboratories, Inc, a global leader in life science research and clinical diagnostics products, today announced the expansion of its TrailBlazer StarBright Dye Label Kits, offering a convenient method for conjugating antibodies to premium...

Hongene Demonstrates Advanced Oligonucleotide CDMO Capabilities Through Support of SiranBio’s Dual-Target siRNA Program 5 May 2026 -- Singapore, Singapore -- Hongene Biotech Corporation today announced its support of SiranBio’s SA1211 program, a dual-target siRNA candidate for chronic hepatitis B, underscoring Hongene’s ability to deliver end-to-end development and manufacturing solutions for structurally complex oligonucleotide therapeutics.

Lab Thread introduces Unified Lab Software Platform to streamline biological research Connects scientific teams, data and workflows within a single, fully integrated digital lab management system 30 April 2026 -- Silverstone, UK -- Lab Thread Ltd, a UK-based life science software company, today announced the worldwide commercial release of its Unified Lab Software Platform.

Impli to accelerate real-time hormone monitoring technology at Birmingham’s PHTA 22 April 2026 -- Birmingham, UK -- Impli, a pioneering health technology company developing implantable biosensors for real-time hormone monitoring, has become the first commercial lab resident at Birmingham’s PHTA, targeting team growth, human trials and manufacturing readiness.

UK biotech launches world-first lab-grown human muscle platform to transform drug testing A pioneering UK biotech company is set to transform the drug testing market with the development of advanced, lab-grown human muscle. Myomaker Bio has developed advanced human muscle models designed to more accurately replicate how medicines behave in the human body The business aims to accelerate drug development and reduce reliance on animal testing.

OMRON and Dassault Systèmes Partner to Bridge the Virtual and the Real Worlds for Flexible, High-Performance Manufacturing OMRON and Dassault Systèmes combine their respective expertise in virtual twins and industrial automation technologies to transform industrial production Information technology and operational technology converge to replace fragmented industrial systems with AI-driven, software-defined manufacturing Manufacturers can validate production systems virtually before deploying...

Bruker Launches MyGenius PRO High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 17 April 2026 -- Munich, Germany -- At ESCMID Global 2026, the Bruker Microbiology & Infection Diagnostics division announces the European launch of MyGenius PRO, a fully automated, sample-to-answer (S2A) molecular diagnostics system based on PCR (Polymerase Chain Reaction) technology.

Novo Nordisk and OpenAI partner to transform how medicines are discovered and delivered Strategic partnership enables upskilling of Novo Nordisk’s workforce and places the company at the forefront of AI transformation in healthcare Novo Nordisk will integrate OpenAI's most advanced AI capabilities globally from drug discovery to commercial operations, empowering talent to move faster, work smarter, and deliver life-changing outcomes for patients The partnership has been structured with strict...